LISAvienna: Read our August 2024 newsletter online

Name: _pk_id Used for : Is used to store an unique ID for each user Duration : 13 Months
Name: &nbsp;_pk_ses, _pk_cvar, _pkhsr Used for :&nbsp;Session cookies that store temporary data Duration :&nbsp;30 minutes
Name: mtm_consent Used for : Stores cookie preferences Duration : 30 years

Learn more about the last weeks’ highlights, upcoming event and opportunities for funding and support.

In this edition of our newsletter, we’re bringing you some of the latest and most exciting developments in Vienna’s life sciences sector including news from MedUni Vienna, Valneva, QUANTRO Therapeutics, LGB, invIOs, MADx, APEIRON Biologics, Boehringer Ingelheim, Cutanos, FFoQSI, CeMM or Uni Vienna. In addition, we list headlines from numerous additional organizations, conferences, trade shows and open calls. Enjoy reading!

Read the newsletter online: https://mailchi.mp/lisavienna/newsletter-august-27-2024
Register for our free mailing lists: https://www.lisavienna.at/newsletter/

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.

LISAvienna: Read our August 2024 newsletter online

Valneva announces the success of its private placement wraising approximately €60 million

Vetmeduni Vienna: Tödlich für Mensch und Tier: Studie liefert neues Wissen zur Verbreitung des Bornavirus

FFG FORUM 2024: „20 Jahre Zukunft: Perspektiven für den Innovationsstandort Österreich“